Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
andrea.picchiantidiamanti@uniroma1.it
Andrea Picchianti Diamanti
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
andrea.picchiantidiamanti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Clinical and ultrasonographic remission in bio-naïve and bio-failure patients with rheumatoid arthritis at 24 weeks of upadacitinib treatment: the UPARAREMUS real-life study
RHEUMATOLOGY AND THERAPY
2024
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
BIOMEDICINES
2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
VACCINES
2023
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies
REUMATISMO
2023
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
AUTOIMMUNITY REVIEWS
2023
Safety of multiple vaccinations and durability of vaccine‐induced antibodies in an Italian military cohort 5 years after immunization
BIOMEDICINES
2022
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2022
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
FRONTIERS IN IMMUNOLOGY
2022
Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: a prospective multicenter longitudinal study
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2022
Editorial: Chronic autoimmune arthritis, infections and vaccines
FRONTIERS IN IMMUNOLOGY
2022
Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome.
ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS
2022
Immunogenicity of viral vaccines in the italian military
BIOMEDICINES
2021
Inhibition of phosphodiesterase-4 in psoriatic arthritis and inflammatory bowel diseases
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Vitamin d signaling in gastro-rheumatology. From immuno-modulation to potential clinical applications
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
May bacterial infections trigger bullous pemphigoid? Case report and review of literature
MICROORGANISMS
2021
Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice
ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ
2021
Immunosuppressive Therapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
FRONTIERS IN IMMUNOLOGY
2021
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases
THE JOURNAL OF RHEUMATOLOGY
2021
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later. The Era of Vaccines
FRONTIERS IN IMMUNOLOGY
2021
Direct and indirect impact of covid‐19 for patients with immune‐mediated inflammatory diseases. A retrospective cohort study
JOURNAL OF CLINICAL MEDICINE
2021
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma